Bioceres Crop Solutions Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Bioceres Crop Solutions hat ein Gesamteigenkapital von $348.5M und eine Gesamtverschuldung von $242.8M, wodurch sich der Verschuldungsgrad auf 69.7% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen $836.1M bzw. $487.6M. Bioceres Crop Solutions Das EBIT des Unternehmens beträgt $36.0M, so dass der Zinsdeckungsgrad 1.6 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von $32.8M.

Wichtige Informationen

74.3%

Verhältnis von Schulden zu Eigenkapital

US$259.66m

Verschuldung

Zinsdeckungsgrad1.7x
BargeldUS$56.17m
EigenkapitalUS$349.56m
GesamtverbindlichkeitenUS$501.06m
GesamtvermögenUS$850.63m

Jüngste Berichte zur Finanzlage

Recent updates

Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Sep 28
Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Bioceres' Q4 2024 Shows Challenges With HB4 Rollout, Still A Hold Despite Lower Stock Prices

Sep 17

These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Aug 03
These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Bioceres Needs To Add Clarity Around Borrowings

Mar 23

Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Feb 03
Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Oct 04
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Jun 21
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

May 09
Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings

Sep 06

Bioceres Crop Solutions jumps 15% after investor pitch

Aug 23

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Mar 31

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products

May 10

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: BIOXDie kurzfristigen Aktiva des Unternehmens ($407.2M) übersteigen seine kurzfristigen Passiva ($333.0M).

Langfristige Verbindlichkeiten: BIOXDie kurzfristigen Vermögenswerte des Unternehmens ($407.2M) übersteigen seine langfristigen Verbindlichkeiten ($154.6M).


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: BIOXDie Nettoverschuldung im Verhältnis zum Eigenkapital (60.3%) wird als hoch angesehen.

Schulden abbauen: BIOX Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 219.5% auf 69.7% zurückgegangen.

Schuldendeckung: BIOXDie Schulden des Unternehmens sind nicht ausreichend durch den operativen Cashflow (4.1%) gedeckt.

Zinsdeckung: BIOXDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (1.6x Deckung) nicht gut gedeckt.


Bilanz


Entdecken Sie finanziell stabile Unternehmen